Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.
HAS-BLED Score Calculator
For estimating the 1-year risk of major bleeding in patients with Atrial Fibrillation.
The HAS-BLED Score is a clinical prediction rule developed to estimate the one-year risk of major bleeding in patients with Atrial Fibrillation (AF) who are starting or currently taking anticoagulation therapy.
While tools like the CHAâ‚‚DSâ‚‚-VASc score determine the risk of stroke (the “benefit” of anticoagulation), the HAS-BLED score helps clinicians quantify the “risk,” allowing for a balanced, patient-specific approach to stroke prevention (Pisters et al., 2010).
The HAS-BLED Scoring System
The acronym stands for the clinical factors used in the calculation. Each factor is assigned 1 point, with a maximum total score of 9.
Scoring Variables
| Letter | Clinical Factor | Definition |
| H | Hypertension | Systolic BP $> 160$ mmHg |
| A | Abnormal Renal/Liver Function | 1 point for each (Max 2) |
| S | Stroke History | Previous ischemic or hemorrhagic stroke |
| B | Bleeding History | Prior major bleed or predisposition to bleeding |
| L | Labile INR | Time in Therapeutic Range $< 60\%$ (for Warfarin users) |
| E | Elderly | Age $\ge 65$ years |
| D | Drugs or Alcohol | 1 point for antiplatelets/NSAIDs; 1 point for $\ge 8$ drinks/week |
Predicting Bleeding Risk
The total score correlates with the number of “Major Bleeds” per 100 patient-years. A “Major Bleed” is typically defined as an intracranial hemorrhage, a bleed requiring hospitalization, or a drop in hemoglobin $> 2$ g/dL.
- Score 0–2: Low to Moderate Risk. Anticoagulation is generally considered safe.
- Score $\ge$ 3: High Risk. These patients require caution and regular clinical review.
Important Clinical Note: A high HAS-BLED score is not an absolute contraindication to anticoagulation. Instead, it identifies patients who need closer monitoring and the aggressive management of “modifiable” risk factors (Lip et al., 2011).
Clinical Application: Modifiable vs. Non-Modifiable Factors
The true value of the HAS-BLED score lies in its ability to highlight areas where a clinician can intervene to lower a patient’s risk profile.
- Modifiable Factors: Controlling blood pressure (the ‘H’), stopping unnecessary NSAID use (the ‘D’), and improving INR control (the ‘L’).
- Non-Modifiable Factors: Age (the ‘E’) and prior stroke history (the ‘S’).
By addressing the modifiable factors, a clinician may effectively lower a patient’s score from a “high risk” 3 to a “moderate risk” 2, making long-term anticoagulation significantly safer (January et al., 2019).
Comparison with Other Scores
The European Society of Cardiology (ESC) guidelines currently favor the HAS-BLED score over others (like HEMORRâ‚‚HAGES or ATRIA) because of its simplicity and its specific validation in AF cohorts. It has shown superior predictive accuracy for intracranial hemorrhage, the most feared complication of oral anticoagulants (Pisters et al., 2010).
References
- Pisters, R., et al. (2010). A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest, 138(5), 1093-1100. https://doi.org/10.1378/chest.10-0779
- Lip, G. Y., et al. (2011). Comparative validation of a novel risk score (HAS-BLED) for assessing 1-year risk of major bleeding in atrial fibrillation: the RE-LY trial. Journal of the American College of Cardiology, 57(2), 173-180.
- January, C. T., et al. (2019). 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation, 140(2), e125-e151. https://doi.org/10.1161/CIR.0000000000000665
- Hindocha, C., et al. (2021). Bleeding risk scores in atrial fibrillation: helpful or a hindrance? European Heart Journal.
